Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00402194 · ClinicalTrials.gov registry record · NA
Treating the Endothelium to Restore Insulin Sensitivity
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT00402194 is a NA study that has completed, run by Indiana University. The registered enrollment target is 17 participants.
The verdict
NCT00402194, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
A study of 12 weeks' treatment with losartan or placebo, to test the hypothesis that RAS inhibition will improve insulin' vascular actions and therefore improve insulin sensitivity in skeletal muscle.
Interventions
- DRUG Losartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2005-06 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00402194
The ClinicalTrials.gov registry entry for NCT00402194 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Losartan is the first listed.
NCT00402194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00402194 about?
NCT00402194 is a clinical study titled "Treating the Endothelium to Restore Insulin Sensitivity". A study of 12 weeks' treatment with losartan or placebo, to test the hypothesis that RAS inhibition will improve insulin' vascular actions and therefore improve insulin sensitivity in skeletal muscle.
What is the current status of trial NCT00402194?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2005-06. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00402194?
The interventions under investigation include: Losartan (DRUG).
Who is sponsoring clinical trial NCT00402194?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.